Healthcare has a completion problem. Not a data problem, not a detection problem, and not a risk-stratification problem. Those were the hard problems of the last decade. By most measures, the industry solved them. What it hasn't solved — and what is getting more costly to ignore — is the gap between the care a patient is identified as needing and the care they actually receive.
That gap has always existed. What's changed is the stakes. Rising quality thresholds, persistent staffing shortages, tighter operating margins, and more fragmented care journeys have all made the completion gap more expensive — and more visible — than it has ever been. The organizations still treating this as an analytics problem are solving for last decade's bottleneck.
The Industry Mastered Identification. The Bottleneck Moved.
Over the past decade, health plans and providers made substantial, real investments in identification. Claims-based gap lists, HEDIS and Stars algorithms, HCC risk models, and referral management systems now flag — with reasonable precision — which patients are overdue for a mammogram, which are drifting off their diabetes medication, and which just left the ED and need follow-up within 72 hours. That is genuine progress. It took years and it works.
But the investment was lopsided. For every dollar that went into identifying who needs care, far less went into the operational infrastructure required to close those gaps. As a result, the bottleneck simply moved downstream — from the gap list to the last mile. The industry knows more about its patients than ever before. And it is still failing to convert that knowledge into completed, documented care at the scale the data demands.
Why This Matters More Now Than It Did Three Years Ago
This is not a perennial observation dressed up as urgency. The conditions that make the completion gap so costly have shifted materially.
Stars thresholds keep rising as quality-bonus revenue compounds. MA quality-bonus payments exceeded $12.7 billion in 2025 — more than four times the 2015 total. The enrollment-weighted MA-PD average rating fell from 4.07 to 3.92 in a single year, and the share of enrollees in 4-star-plus plans dropped from 74% to 62%. That is not a trend line heading in a forgiving direction. Every open gap that doesn't close is direct exposure to a quality bonus that won't materialize.
Post-pandemic staffing constraints never fully normalized. The workforce attrition that began during COVID-19 left a durable shortage of clinical and administrative staff — precisely the people who do the unglamorous, essential work of follow-up, outreach, and care coordination. Cancer screening rates still haven't recovered to pre-pandemic levels. Chronic staffing gaps mean that the old answer — scale up your call center, hire more care coordinators — is neither financially viable nor operationally realistic for most organizations.
Referral failure is not a minor inefficiency. It is a structural loss. An estimated 65% of referral attempts never convert into a completed appointment. Providers face a 19% average no-show rate. Research published in the Journal of General Internal Medicine found that 38.1% of Medicare patients reported at least one gap in care coordination, and those gaps were associated with 55% greater adjusted odds of a preventable adverse outcome — avoidable ED visits, unnecessary hospital admissions, compounding clinical and financial costs. Access barriers accounted for three of the top five reasons patients cited for postponing care, according to the 2025 McKinsey Physician Survey. These are not soft metrics. They are the mechanism by which identified risk translates into avoidable harm and avoidable spending.
The completion gap is not confined to older or high-risk populations. A 2022–23 analysis using National Health Interview Survey data found that more than 1 in 4 young adults experienced a care gap lasting a year or more, with the absence of insurance and a usual source of care serving as reliable predictors across every age group. This is a structural feature of American healthcare, not a Medicare Advantage problem.
Higher-acuity care has raised the cost of operational failure. As care becomes more specialized — more targeted therapies, more complex referral pathways, more expensive precision treatments — the downstream cost of a missed follow-up, a misdirected referral, or an unconfirmed post-discharge plan grows proportionally. Operational failures in the last mile are no longer just missed wellness visits. They are mismanaged care transitions for patients who can't afford the gap.
Why More Analytics Won't Solve It
The instinct when performance stalls is to invest in better identification tools — finer segmentation, richer models, more data sources. That instinct is understandable. It's also a category error.
A more accurate gap list does not close a single gap. It produces a longer, more precisely ranked list of patients still not getting care. And scaling human outreach to match the problem — hiring enough schedulers and care coordinators to personally reach every at-risk member at the right time, in the right language, through the right channel — doesn't pencil for any organization operating under current staffing realities and margin pressure.
This is the core tension that healthcare leaders now face: the volume of identified gaps has grown faster than the operational capacity to close them, and the financial consequences of that mismatch are accelerating. Neither more analytics nor more headcount, on its own, resolves it. What's required is a fundamentally different approach to execution — one that can operate at population scale, personalize every interaction, escalate to clinical judgment when it matters, and return a documented, auditable outcome that counts for quality and compliance purposes.
The Reallocation Healthcare Leaders Need to Consider
Healthcare executives across Quality, Stars, Care Management, and Population Health are not short on visibility into where their gaps are. They are increasingly short on the operational infrastructure to close them — at scale, efficiently, and in a way that proves it happened.
The data is pointing to a reallocation: away from identification as the primary investment, and toward execution as the discipline that determines whether identification ever translates into outcomes.
The organizations that make this shift first won't just close more gaps. They'll close the distance between what their data already knows and what their patients actually experience. In 2026 — with quality thresholds rising, staffing remaining constrained, and the financial stakes compounding — that distance is healthcare's most expensive operational problem.
This is the first in a series examining the completion gap in healthcare — why it persists, what it costs now, and what closing it at scale actually requires.
